| 摘要 |
The invention provides antibodies that specifically bind to PD-1, nucleic acid molecules encoding the same, and therapeutic compositions thereof. The agents inhibit PD-1 -mediated immunosuppression and enhance cell and cytokine mediated immunity for the treatment of neoplastic and infectious diseases. |
